Topiramate Capsule, Coated Pellets
Product Images NDC 70518-4247

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-4247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (61ea1fc2 B691 4c09 Ac57 B37347dba975 01)

Structured Product Formula For Topiramate (61ea1fc2 B691 4c09 Ac57 B37347dba975 01)
Chemical structure of topiramate, showing its molecular arrangement with oxygen, sulfur, nitrogen atoms, and tert-butyl groups attached to a sugar-like ring system.*
FDA Label Image

Structured Product Formula For Topiramate (61ea1fc2 B691 4c09 Ac57 B37347dba975 02)

Structured Product Formula For Topiramate (61ea1fc2 B691 4c09 Ac57 B37347dba975 02)
A Kaplan-Meier survival curve showing cumulative rates for time to first seizure over 500 days for topiramate at 50 mg/day and 400 mg/day doses. The graph compares two groups (N=234 and N=236), with the higher dose group exhibiting a lower cumulative seizure rate over time.*
FDA Label Image

Topiramate Tablets Usp (61ea1fc2 B691 4c09 Ac57 B37347dba975 03)

Topiramate Tablets Usp (61ea1fc2 B691 4c09 Ac57 B37347dba975 03)
A bar chart showing change from baseline to double-blind phase in average monthly migraine period rate with topiramate treatment. Data are shown for placebo and topiramate doses of 50 mg/day, 100 mg/day, and 200 mg/day from two studies (Study 11 and Study 12). The chart displays reduction in migraine rate with increasing dosages of topiramate, highlighting statistical significance levels at p < 0.010 and p < 0.001.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a label for topiramate 25 mg capsules, with 30 capsules per box, labeled by RemedyRepack Inc. It includes a barcode, NDC 70518-4247-00, manufacturing info from Zydus Pharm in Pennington, NJ, and storage instructions. The label emphasizes prescription use and advises keeping the medication out of children's reach.*
FDA Label Image

Mm2 (Topiramate 25mg 70518 4247 01)

Mm2 (Topiramate 25mg 70518 4247 01)
Topiramate 25 mg capsule with quantity of 1 capsule visible on the label. The label includes the NDC number 70518-4247-01, manufacturer Zydus Pharmaceuticals, Pennington, NJ, and repackager Remedy Repack Inc., Indiana, PA. Storage instructions and a barcode are also displayed, along with a warning to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.